Weave Bio is an AI-native regulatory automation management platform redefining regulatory submissions for novel therapeutic candidates. Designed for pharma, biotechs, CROs, and consultants, the Weave Platform streamlines regulatory document preparation and lifecycle management by automating initial draft documents, extracting key insights, and integrating study data into a seamless, AI-enabled workflow.
The platform accelerates regulatory processes, enabling faster drafting, high-quality reviews, and compliance with global standards. AutoIND, widely adopted for preclinical IND submissions, earned the “Biotech AI Innovation of the Year” award. And with AutoCT, Weave expanded capabilities into clinical-stage submissions, building the foundation for a singular AI workbench for the entire therapy lifecycle.
Backed by top investors in AI and life sciences, Weave is creating a new AI-enabled, human-driven platform to enhance efficiency, submission quality, and cost-effectiveness.
For more information, visit weave.bio. Interested in a career at Weave? Send your resume to joinourteam@weave.bio.
-
Industry
-
Pharmaceutical Manufacturing
-
Company size
-
11-50 employees
-
Headquarters
-
San Francisco, CA
-
Type
-
Privately Held
-
Founded
-
2023
-
Specialties
-
Regulatory document automation, Regulatory document preparation, Preclinical Document Authoring, Clinical Protocol Development, IND Authoring, Investigator’s Brochure (IB) Preparation, Clinical Study Report (CSR) Automation, Regulatory Strategy Alignment, AI-Assisted Medical Writing, eCTD-Ready Document Formatting, Clinical & Regulatory Lifecycle , Global Submission Readiness, Safety Narrative Compilation, and Automated Workflow for Regulatory Compliance